Durgical
EN
Open the app

The skin in HIV

  • Disease group

The skin is often the first place HIV shows itself. Some skin signs mean the immune system is failing and should prompt an HIV test that same day.

Updated

See it in 3D: Skin

What it is

Most people living with HIV develop skin or mouth disease at some point. The causes fall into five groups: the rash of acute HIV; infections that become frequent or extreme (herpes zoster, chronic herpes simplex, widespread molluscum, oral candidiasis and hairy leukoplakia, and disseminated fungi such as Cryptococcus, Histoplasma and Talaromyces, or Bartonella causing bacillary angiomatosis); inflammatory dermatoses (severe seborrhoeic dermatitis, eosinophilic folliculitis, papular pruritic eruption, worsening psoriasis); tumours (Kaposi sarcoma from HHV-8, and HPV-related squamous cancers); and drug reactions, which are far more common. Starting antiretroviral therapy (ART) can unmask or inflame infections and Kaposi sarcoma: the immune reconstitution inflammatory syndrome (IRIS).

How to recognise it

  • Acute HIV: fever, sore throat, nodes and a morbilliform rash on the trunk, sometimes mouth ulcers, weeks after exposure; antibody tests may still be negative.
  • Signs that should prompt an HIV test: zoster in a young adult or across several dermatomes, severe seborrhoeic dermatitis, oral candidiasis or hairy leukoplakia, many or giant facial molluscum, chronic herpes ulcers, any STI.
  • Umbilicated facial papules with fever in advanced HIV may be disseminated cryptococcosis, histoplasmosis or talaromycosis, not molluscum.
  • Kaposi sarcoma: violaceous-brown macules, plaques or nodules on the skin, hard palate and legs, often with oedema; it can also involve the gut and lungs.
  • Drug eruptions are much more common, including SJS/TEN with sulfonamides and nevirapine.
  • IRIS: weeks after starting ART, a known or hidden infection or Kaposi sarcoma flares as immunity recovers.

Skin signs in HIV and the immune level they suggest

Skin findingCauseImmune levelClue
Morbilliform rash with feverAcute HIVNormal (seroconversion)Recent exposure; viral load or antigen/antibody test
ZosterVaricella-zoster virusAnyYoung adult, several dermatomes, recurrences
Severe seborrhoeic dermatitisMalassezia and immune imbalanceFallingScaly red face, scalp and chest
Itchy follicular papules on face and upper trunkEosinophilic folliculitisLowIntense itch; biopsy
Many or giant molluscumMolluscum virusLowFace; umbilicated domes
Molluscum-like papules with feverCryptococcosis, histoplasmosis, talaromycosisVery lowSystemically ill; biopsy and culture
Red-purple vascular papulesBacillary angiomatosis (Bartonella)Very lowCat contact; mimics Kaposi sarcoma or pyogenic granuloma
Violaceous plaques and nodulesKaposi sarcoma (HHV-8)Any, mostly lowHard palate, legs, oedema
Chronic painful ulcersHerpes simplex virusLowPerianal or genital, lasting weeks

In the clinic

  • In Colombia, HIV testing is covered by the health system and HIV is a notifiable event; any of these skin clues is a reason to offer the test that day, with consent and counselling.
  • ART is also the best skin treatment: many HIV-related dermatoses fade as immunity recovers.
  • Squamous cancers of the skin, anus and genitals are more frequent: examine these areas and arrange screening.
  • Syphilis can be atypical in HIV (many lesions, ulcerating forms, early neurosyphilis); test for both every time.
  • Prophylactic sulfamethoxazole-trimethoprim is a frequent cause of drug rash; check the mucosae and organs before deciding to continue.

Next step

  • Offer an HIV test (rapid test or fourth-generation antigen/antibody test) to anyone with these skin clues; viral load if acute HIV is suspected.
  • Biopsy unusual papules, nodules or ulcers for histology, special stains and culture (fungi, mycobacteria, Bartonella, HHV-8).
  • Start or adjust ART with the HIV programme; check the CD4 count and screen for syphilis, hepatitis and tuberculosis.
  • Refer to the HIV programme and dermatology: Kaposi sarcoma, disseminated fungal infection, SJS/TEN and IRIS need specialist care.

Common traps

  • Shingles in a 25-year-old is just stress: zoster in a young adult is a reason to offer an HIV test.
  • Umbilicated facial papules in advanced HIV are always molluscum: disseminated fungi look the same; biopsy if the patient has fever.
  • A flare after starting ART means the drugs are failing: it is often IRIS, a sign of recovering immunity; drug hypersensitivity must still be excluded.
  • A negative antibody test rules out HIV in a feverish patient with a new rash: early in acute HIV antibodies are absent; test viral load or p24 antigen.

Test yourself

Think of the answer, then tap the question to see it.

A 28-year-old has zoster across two dermatomes and a scaly red face. What should be offered and why?

An HIV test: early-onset or multidermatomal zoster and severe seborrhoeic dermatitis are classic signs of immunodeficiency.

Why is an umbilicated facial papule in a febrile patient with very low CD4 biopsied instead of treated as molluscum?

Disseminated Cryptococcus, Histoplasma or Talaromyces can look like molluscum and are fatal without systemic antifungal treatment.

Six weeks after starting ART, a patient's Kaposi lesions swell and new nodes appear. What is happening?

Immune reconstitution inflammatory syndrome: the recovering immune response inflames existing disease; ART usually continues with specialist care.

Add to my cards (3)

Elsewhere in DurgiPedia

Connections

← All of dermatology

Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.

Sources: Kaposi Sarcoma (StatPearls Publishing (NCBI Bookshelf), 2024); Bacillary Angiomatosis (StatPearls Publishing (NCBI Bookshelf), 2024); Seborrheic Dermatitis (StatPearls Publishing (NCBI Bookshelf), 2024); Molluscum Contagiosum (StatPearls Publishing (NCBI Bookshelf), 2024); HIV and AIDS (World Health Organization, 2024).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.